Glucocorticoid excess and the developmental origins of disease: Two decades of testing the hypothesis - 2012 Curt Richter Award Winner

Psychoneuroendocrinology

Volumn 38, Issue 1, 2013, Pages 1-11

  Reynolds, Rebecca M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Birthweight; Cognitive decline; Glucocorticoids; Hypothalamic pituitary adrenal axis; Metabolic syndrome; Programming

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOTROPIN; GLUCOCORTICOID; HYDROCORTISONE;

ADULTHOOD; BLOOD PLACENTA BARRIER; BRAIN DISEASE; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CLINICAL EVALUATION; COGNITIVE DEFECT; CORTICOSTEROID BLOOD LEVEL; CORTICOSTEROID METABOLISM; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; DISORDERS OF HORMONE METABOLISM; DRUG EXPOSURE; ENZYME ACTIVITY; ENZYME METABOLISM; EXPERIMENTAL MODEL; FETUS DEVELOPMENT; FETUS MONITORING; HABITUATION; HORMONE ACTION; HORMONE DETERMINATION; HORMONE RESPONSE; HORMONE STRUCTURE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LOW BIRTH WEIGHT; MENTAL STRESS; METABOLIC DISORDER; METABOLIC SYNDROME X; MOOD CHANGE; NEGATIVE FEEDBACK; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROGENY; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; RISK FACTOR; TRANSLATIONAL RESEARCH; TREATMENT RESPONSE; TREND STUDY; UTERUS; VEIN PUNCTURE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADAPTATION, PHYSIOLOGICAL; ADULT; ANIMALS; AWARDS AND PRIZES; BRAIN DISEASES, METABOLIC; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; CUSHING SYNDROME; DEVELOPMENTAL DISABILITIES; FEEDBACK, PHYSIOLOGICAL; FEMALE; FETUS; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MATERNAL-FETAL EXCHANGE; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; NEUROENDOCRINOLOGY; NEUROPSYCHOLOGY; PITUITARY-ADRENAL SYSTEM; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 84870393060     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.08.012     Document Type: Review

References (98)

1. Alevizaki M., Cimponeriu A., Lekakis J., Papamichael C., Chrousos G.P. High anticipatory stress plasma cortisol levels and sensitivity to glucocorticoids predict severity of coronary artery disease in subjects undergoing coronary angiography. Metabolism 2007, 56:222-226.
2. Andrews R.C., Herlihy O., Livingstone D.E.W., Andrew R., Walker B.R. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J. Clin. Endocrinol. Metab. 2002, 87:5587-5593.
3. Bamberger C.M., Schulte H.M., Chrousos G.P. Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr. Rev. 1996, 17:245-261.
4. Barker D.J.P., Gluckman P.D., Godfrey K.M., Harding J.E., Owens J.E., Robinson J.S.e Fetal nutrition and cardiovascular disease in adult life. Lancet 1993, 341:938-941.
5. Barker D.J.P. Fetal origins of coronary heart disease. Br. Med. J. 1995, 311:171-174.
6. Brown R.W., Diaz R., Robson A.C., Kotelevtsev Y.V., Mullins J.J., Kaufman M.H., Seckl J.R. The ontogeny of 11beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology 1996, 137:794-797.
7. Bergman K., Sarkar P., Glover V., O'Connor T.G. Maternal prenatal cortisol and infant cognitive development: moderation by infant-mother attachment. Biol. Psychiatry 2010, 67(11):1026-1032.
8. Benediktsson R., Lindsay R.S., Noble J., Seckl J.R., Edwards C.R.W. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 1993, 341:339-341.
9. Benediktsson R., Calder A.A., Edwards C.R., Seckl J.R. Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin. Endocrinol. 1997, 46(2):161-166.
10. Bolten M.I., Wurmser H., Buske-Kirschbaum A., Papousek M., Pirke K.M., Hellhammer D. Cortisol levels in pregnancy as a psychobiological predictor for birth weight. Arch. Womens Ment. Health 2011, 14:33-41.
11. Broyd S.J., Demanuele C., Debener S., Helps S.K., James C.J., Sonuga-Barke E.J. Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci. Biobehav. Rev. 2009, 33(3):279-296.
12. Buss C., Poggi Davis E., Shahbaba B., Pruessner J.C., Head K., Sandman C.A. Maternal cortisol over the course of pregnancy and subsequent child amygdala and hippocampus volumes and affective problems. Proc. Natl. Acad. Sci. U.S.A. 2012, E1312-E1319.
13. Campbell E.A., Linton E.A., Wolfe C.D., Scrages P.R., Jones M.T., Lowry P.J. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J. Clin. Endocrinol. Metab. 1987, 64:1054-1059.
14. Cole T.J., Blendy J.A., Monaghan A.P., Schmid W., Aguzzi A., Schutz G. Molecular genetic analysis of glucocorticoid signaling during mouse development. Steroids 1995, 60:93-96.
15. Cottrell E.C., Holmes M.C., Livingstone D.E., Kenyon C.J., Seckl J.R. Reconciling the nutritional and glucocorticoid hypotheses of fetal programming. FASEB J. 2012, 26(5):1866-1874.
16. Cottrell E.C., Seckl J.R. Prenatal stress, glucocorticoids and the programming of adult disease. Front. Behav. Neurosci. 2009, 3:19.
17. Dalziel S.R., Walker N.K., Parag V., Mantell C., Rea H.H., Rodgers A., Harding J.E. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet 2005, 365:1856-1862.
18. Dave-Sharma S., Wilson R.C., Harbison M.D., Newfield R., Azar M.R., Krozowski Z.S., Funder J.W., Shackleton C.H., Bradlow H.L., Wei J.Q., Hertecant J., Moran A., Neiberger R.E., Balfe J.W., Fattah A., Daneman D., Akkurt H.I., De Santis C., New M.I. Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 1998, 83:2244-2254.
19. Davis E.P., Glynn L.M., Waffarn F., Sandman C.A. Prenatal maternal stress programs infant stress regulation. J. Child Psychol. Psychiatr. 2011, 52:119-129.
20. de Rooij, Painter R.C., Phillips D.I., Osmond C., Michels R.P., Bossuyt P.M., Bleker O.P., Roseboom T.J. Hypothalamic-pituitary-adrenal axis activity in adults who were prenatally exposed to the Dutch famine. Eur. J. Endocrinol. 2006, 155:153-160.
21. Diego M.A., Jones N.A., Field T., Hernandez-Reif M., Schanberg S., Kuhn C., Gonzalex-Garcia A. Maternal psychological distress, prenatal cortisol and fetal weight. Pyschosom. Med. 2006, 68:747-753.
22. Drake A.J., McPherson R.C., Godfrey K.M., Cooper C., Lillycrop K.A., Hanson M.A., Meehan R.R., Seckl J.R., Reynolds R.M. An unbalanced maternal diet in pregnancy associates with offspring epigenetic changes in genes controlling glucocorticoid action and fetal growth. Clin. Endocrinol. 2012, 10.1111/j.1365-2265.2012.04453.x.
23. Doyle L.W., Ford G.W., Davis N.M., Callanan C. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin. Sci. 2005, 98:137-142.
24. Edwards C.E., Benediktsson R., Lindsay R.S., Seckl J.R. Dysfunction of the placental glucocorticoid barrier: a link between the foetal environment and adult hypertension?. Lancet 1993, 341:355-357.
25. Entringer S., Buss C., Andersen J., Chicz-DeMet A., Wadhwa P.D. Ecological momentary assessment of maternal cortisol profiles over a multiple-day period predicts the length of human gestation. Psychsom. Med. 2011, 73(6):469-474.
26. Entringer S., Buss C., Wadhwa P.D. Prenatal stress and developmental programming of human health and disease risk: concepts and integration of empirical findings. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17(6):507-516.
27. Fall C.H., Dennison E., Cooper C., Pringle J., Kellingray S.D., Hindmarsh P. Does birth weight predict adult serum cortisol concentrations? Twenty-four-hour profiles in the United kingdom 1920-1930 Hertfordshire Birth Cohort. J. Clin. Endocrinol. Metab. 2002, 87(5):2001-2007.
28. Filiberto A.C., Maccani M.A., Koestler D., Wilhelm-Benartzi C., Avissar-Whiting M., Banister C.E., Gagne L.A., Marsit C.J. Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta. Epigenetics 2011, 6(5):566-572.
29. French N.P., Hagan R., Evans S.F., Godfrey M., Newnham J.P. Repeated antenatal corticosteroids: size at birth and subsequent development. Am. J. Obstet. Gynecol. 1999, 180:112-121.
30. Gardner D.S., Jackson A.A., Langley-Evans S.C. Maintenance of maternal diet-induced hypertension in the rat is dependent on glucocorticoids. Hypertension 1997, 30:1525-1530.
31. Geoffroy M.C., Hertzman C., Li L., Power C. Morning salivary cortisol and cognitive function in mid-life: evidence from a population-based birth cohort. Psychol. Med. 2011, 1:1-11.
32. Gitau R., Cameron A., Fisk N.M., Glover V. Fetal exposure to maternal cortisol. Lancet 1998, 352:707-708.
33. Gitau R., Fisk N.M., Glover V. Human fetal and maternal corticotrophin releasing hormone responses to acute stress. Arch. Dis. Child. Fetal Neonatal Ed. 2004, 89:F29-F32.
34. Gitau R., Fisk N.M., Teizerira J.M., Cameron A., Glover V. Fetal hypothalamic-pituitary-adrenal stress responses to invasive procedures are independent of maternal responses. J. Clin. Endocrinol. Metab. 2001, 86:104-109.
35. Goedhart G., Vrijkotte T.G.M., Roseboom T.J., Van der Wal M.F., Cuijpers P., Bonsel G.J. Maternal cortisol and offspring birthweight: results from a large prospective cohort study. Psychoneuroendocrinology 2010, 35:644-652.
36. Goland R.S., Jozak S., Conwell I. Placental corticotropin-releasing hormone and the hypercortisolism of pregnancy. Am. J. Obstet. Gynecol. 1994, 171:1287-1291.
37. Haller J., Mikics E., Makara G.B. The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system: a critical evaluation of findings. Front. Neuroendocrinol. 2008, 29:273-291.
38. Harville E.W., Savitz D.A., Dole N., Herring A.H., Thorp J.M. Stress questionnaires and stress biomarkers during pregnancy. J. Womens Health 2009, 18:1425-1433.
39. Harville E., Xiong X., Buekens P. Disasters and perinatal health: a systematic review. Obstetr. Gynecol. Surv. 2010, 65:713-728.
40. Herrmann T.S., Siega-Riz A.M., Hobel C.J., Aurora C., Dunkel Schetter C. Prolonged periods without food intake during pregnancy increase risk for elevated maternal corticotropin-releasing hormone concentrations. Am. J. Obstet. Gynecol. 2001, 185:403-412.
41. Hughes K.A., Reynolds R.M., Andrew R., Critchley H.O., Walker B.R. Glucocorticoids turn over slowly in human adipose tissue in vivo. J. Clin. Endocrinol. Metab. 2010, 95(10):4696-4702.
42. Huh S.Y., Andrew R., Rich-Edwards J.W., Kleinman K.P., Seckl J.R., Gillman M.W. Association between umbilical cord glucocorticoids and blood pressure at age 3 years. BMC Med. 2008, 6:25.
43. Jung C., Ho J.T., Torpy D.J., Rogers A., Doogue M., Lewis J.G., Czajko R.J., Inder W.J. A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J. Clin. Endocrinol. Metab. 2011, 96:1533-1540.
44. Kajantie E., Eriksson J., Barker D.J., Forsen T., Osmond C., Wood P.J., Andersson S., Dunkel L., Phillips D.I. Birth size, gestational age and adrenal function in adult life: studies of dexamethasone suppression and ACTH1-24 stimulation. Eur. J. Endocrinol. 2003, 149:569-575.
45. Kajantie E., Eriksson J., Osmond C., Wood P.J., Forsen T., Barker D.J., Phillips D.I. Size at birth, the metabolic syndrome and 24-h salivary cortisol profile. Clin. Endocrinol. 2004, 60:201-207.
46. Kang H.J., Kawasawa Y.I., Cheng F., Zhu Y., Xi X., Li M., Sousa A.M., Pletikos M., Meyer K.A., et al. Spatio-temporal transcriptome of the human brain. Nature 2011, 478:483-489.
47. Kay H.H., Bird I.M., Coe C.L., Dudley D.J. Antenatal steroid treatment and adverse fetal effects: what is the evidence?. J. Soc. Gyncol. Invest. 2000, 7:269-278.
48. Langley-Evans S.C. Hypertension induced by foetal exposure to a maternal low-protein diet, in the rat, is prevented by pharmacological blockade of maternal glucocorticoid synthesis. J. Hypertens. 1997, 15:537-544.
49. Langley-Evans S.C., Phillips G.J., Benediktsson R., Gardner D.S., Edwards C.R.W., Jackson A.A., Seckl J.R. Protein intake in pregnancy, placental glucocorticoid metabolism and the programming of hypertension in the rat. Placenta 1996, 17:169-172.
50. Levitt N.S., Lindsay R.S., Holmes M.C., Seckl J.R. Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 1996, 64(6):412-418.
51. Levitt N.S., Lambert E.V., Woods D., Hales N., Andrew R., Seckl J.R. Impaired glucose tolerance and elevated blood pressure in low birth weight, nonobese, young South African adults: early programming of cortisol axis. J. Clin. Endocrinol. Metab. 2000, 85:4611-4618.
52. Lindsay J.R., Nieman L.K. The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr. Rev. 2005, 775-799.
53. Lopez-Bernal A., Flint A.P.F., Anderson A.B.M., Turnbull A.C. 11beta hydroxysteroid dehydrogenase activity (EC1.1.1.146) in human placenta and decidua. J. Steroid Biochem. 1980, 13:1081-1087.
54. MacLullich A.M., Deary I.J., Starr J.M., Ferguson K.J., Wardlaw J.M., Seckl J.R. Plasma cortisol levels, brain volumes and cognition in healthy elderly men. Psychoneuroendocrinology 2005, 30:505-515.
55. Mangos G.J., Walker B.R., Kelly J.J., Lawson J.A., Webb D.J., Whitworth J.A. Cortisol inhibits cholinergic vasodilation in the human forearm. Am. J. Hypertens. 2000, 13:1155-1160.
56. Marsit C.J., Maccani M.A., Padbury J.F., Lester B.M. Placental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioural outcome. PLoS ONE 2012, 7(3):e33794.
57. Mattsson C., Reynolds R.M., Simonyte K., Olsson T., Walker B.R. Combined Receptor Antagonist Stimulation of the HPA axis test identifies impaired negative feedback sensitivity to cortisol in obese men. J. Clin. Endocrinol. Metab. 2009, 94:1347-1352.
58. McEwen B.S. Stress and the aging hippocampus. Front. Neuroendocrinol. 1999, 20:49-70.
59. McTernan C.L., Draper N., Nicholson H., Chalder S.M., Driver P., Hewison M., Kilby M.D., Stewart P.M. Reduced placental 11 beta-hydroxsteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. J. Clin. Endocrinol. Metab. 2001, 86:4979-4983.
60. Mesiano S., Jaffe R.B. Developmental and functional biology of the primate fetal adrenal cortex. Endocr. Rev. 1997, 18:378-403.
61. Murphy B.E., Clark S.J., Donald I.R., Pinsky M., Vedady D. Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. Am. J. Obstet. Gynecol. 1974, 118:538-541.
62. Orth D.N., Kovacs W.J., DeBold C.R. The Adrenal Cortex in Williams Textbook of Endocrinology 1992, 489-620. Saunders, Philadelphia. J.D. Wilson, D.W. Foster (Eds.).
63. Ozanne S.E., Constancia M. Mechanisms of disease: the developmental origins of disease and the role of the epigenotype. Nat. Clin. Pract. Endocrinol. Metabol. 2007, 3:539-546.
64. Philip R.C., Dauvermann M.R., Whalley H.C., Baynham K., Lawrie S.M., Stanfield A.C. A systematic review and meta-analysis of the fMRI investigation of autism spectrum disorders. Neurosci. Biobehav. Rev. 2012, 36(2):901-942.
65. Phillips D.I.W, Barker D.J.P., Fall C.H.D., Seckl J.R., Whorwood C.B., Wood P.J., Walker B.R. Elevated plasma cortisol concentrations: an explanation for the relationship between low birthweight and adult cardiovascular risk factors. J. Clin. Endocrinol. Metab. 1998, 83:757-760.
66. Phillips D.I.W., Walker B.R., Reynolds R.M., Flanagan D.E.H., Wood P.J., Osmond C., Barker D.J.P., Whorwood C.B. Low birthweight and elevated plasma cortisol concentrations in adults from three populations. Hypertension 2000, 35:1301-1306.
67. Räikkönen K., Pesonen A.K., Heinonen K., Lahti J., Komsi N., Eriksson J.G., Seckl J.R., Järvenpää A.L., Strandberg T.E. Maternal licorice consumption and detrimental cognitive and psychiatric outcomes in children. Am. J. Epidemiol. 2009, 170(9):1137-1146.
68. Räikkönen K., Seckl J.R., Heinonen K., Pyhälä R., Feldt K., Jones A., Pesonen A.K., Phillips D.I., Lahti J., Järvenpää A.L., Eriksson J.G., Matthews K.A., Strandberg T.E., Kajantie E. Maternal prenatal licorice consumption alters hypothalamic-pituitary-adrenocortical axis function in children. Psychoneuroendocrinology 2010, 2010:1587-1593.
69. Ravelli A.C.J., van der Meulen J.H.P., Michels R.P.J., Osmond C., Barker D.J.P., Hales C.N., Bleker O.P. Glucose tolerance in adults after prenatal exposure to famine. Lancet 1998, 351:173-177.
70. Reynolds R.M., Godfrey K.M., Barker M., Osmond C., Phillips D.I. Stress responsiveness in adult life: influence of mother's diet in late pregnancy. J. Clin. Endocrinol. Metab. 2007, 92:2208-2210.
71. Reynolds R.M., Ilyas B., Price J.F., Fowkes F.G.R., Newby D.E., Webb D.J., Walker B.R. Circulating plasma cortisol concentrations are not associated with coronary artery disease or peripheral vascular disease. QJM 2009, 102:469-475.
72. Reynolds R.M., Labad J., Sears A., Williamson R.M., Strachan M.J., Deary I.J., Lowe G.O., Price J.F., Walker B.R. Glucocorticoid treatment and impaired mood, memory and metabolism in people with type 2 diabetes: the Edinburgh Type 2 diabetes study. Eur. J. Endocrinol. 2012, 166(5):861-868.
73. Reynolds R.M., Labad J., Strachan M.W., Fowkes F.G., Lee A.J., Seckl J.R., Deary I.J., Walker B.R., Price J.F. on behalf of the Edinburgh Type 2 Diabetes Study (ET2DS) Investigators. Elevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes study. J. Clin. Endocrinol. Metab. 2010, 95:1602-1608.
74. Reynolds R.M., Strachan M.W., Labad J., Fowkes F.G.R., Lee A.J., Seckl J.R., Deary I.J., Walker B.R., Price J.F. on behalf of the Edinburgh Type 2 Diabetes Study (ET2DS) Investigators. Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care 2010, 33:714-720.
75. Reynolds R.M., Sydall H.E., Wood P.J., Phillips D.I.W., Walker B.R. Elevated plasma cortisol in glucose intolerant men: different responses to glucose and habituation to venepuncture. J. Clin. Endocrinol. Metab. 2001, 86:1149-1153.
76. Reynolds R.M., Walker B.R. Human insulin resistance: the role of glucocorticoids. Diabetes Obes. Metab. 2003, 5(1):5-12.
77. Reynolds R.M., Walker B.R., McKeigue P.M., Lithell H.O., Chapman K.E., Seckl J.R. Skeletal muscle glucocorticoid receptor density and insulin resistance. J. Am. Med. Assoc. 2002, 287:2505-2506.
78. Reynolds R.M., Walker B.R., Syddall H.E., Andrew R., Wood P.J., Whorwood C.B., Phillips D.I. Altered control of cortisol secretion in adult men with low birthweight and cardiovascular risk factors. J. Clin. Endocrinol. Metab. 2001, 86:245-250.
79. Reynolds R.M., Walker B.R., Syddall H.E., Andrew R., Wood P.J., Phillips D.I. Is there a gender difference in the associations of birthweight and adult hypothalamic-pituitary-adrenal axis activity?. Eur. J. Endocrinol. 2005, 152(2):249-253.
80. Reynolds R.M., Walker B.R., Syddall H.E., Hales C.N., Phillips D.I. Predicting cardiovascular risk factors from plasma cortisol measured during glucose tolerance tests. Metabolism 2003, 52(5):524-527.
81. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst. Rev. 2006, 3:CD004454.
82. Roseboom T., de Rooij S., Painter R. The Dutch famine and its long-term consequences for adult health. Early Hum. Dev. 2006, 82(8):485-491.
83. Rosmond R., Dallman M.F., Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and haemodynamic abnormalities. J. Clin. Endocrinol. Metab. 1998, 83:1853-1859.
84. Sandeep T.C., MacLullich A.M.J., Noble J., Deary I.J., Walker B.R., Seckl J.R. 11b-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:6734-6739.
85. Sandman C.A., Glynn L., Dunkel Schetter C., Wadwha P., Garite T., Chicz-DeMet A., Hobel C. Elevated maternal cortisol early in pregnancy predicts the third trimester levels of placental corticotropin releasing hormone (CRH): priming the placental clock. Peptides 2006, 27:1457-1463.
86. Seckl J.R., Dickson K.L., Yates C., Fink G. Distribution of glucocorticoid and mineralocorticoid receptor messenger RNA expression in human postmortem hippocampus. Brain Res. 1991, 561:332-337.
87. Seckl J.R. Prenatal glucocorticoids and long-term programming. Eur. J. Endocrinol. 2004, 151:49-62.
88. Smith A.K., Jeffrey Newport D., Ashe M.P., Brennan P.A., Laprairie J.L., Calamaras M., Nemeroff C.B., Ritchie J.C., Cubells J.F., Stowe Z.N. Predictors of neonatal hypothalamic-pituitary-adrenal axis activity at delivery. Clin. Endocrinol. 2011, 10.1111/j.1365-2265.2011.03998.x.
89. Smith I.D., Shearman R.P. Fetal plasma steroids in relation to parturition. I. The effect of gestational age upon umbilical plasma corticosteroid levels following vaginal delivery. J. Obstet. Gynaecol. Br. Commonw. 1974, 81:11-15.
90. Stewart P.M., Rogerson F.M., Mason J.I. Type-2 11-beta-hydroxysteroid dehydrogenase messenger-ribonucleic-acid and activity in human placenta and fetal membranes - its relationship to birth-weight and putative role in fetal adrenal steroidogenesis. J. Clin. Endocrinol. Metab. 1995, 80:885-890.
91. Strandberg T.E., Järvenpää A.L., Vanhanen H., McKeigue P.M. Birth outcome in relation to licorice consumption during pregnancy. Am. J. Epidemiol. 2001, 153(11):1085-1088.
92. Strandberg T.E., Andersson S., Järvenpää A.L., McKeigue P.M. Preterm birth and licorice consumption during pregnancy. Am. J. Epidemiol. 2002, 156(9):803-805.
93. Van Dijk A.E., Van Eijsden M., Stronks K., Gemke R.J., Vrijkotte T.G. The relation of maternal job strain and cortisol levels during early pregnancy with body composition in the 5-year-old child: the ABCD study. Early Hum. Dev. 2011, 88(6):351-356.
94. van Montfoort N., Finken M.J., le Cessie S., Dekker F.W., Wit J.M. Could cortisol explain the association between birth weight and cardiovascular disease in later life? A meta-analysis. Eur. J. Endocrinol. 2005, 153:811-817.
95. Ward A.M., Fall C.H., Stein C.E., Kumaran K., Veena S.R., Wood P.J., Syddall H.E., Phillips D.I. Cortisol and the metabolic syndrome in South Asians. Clin. Endocrinol. 2003, 58:500-505.
96. Welberg L.A.M., Seckl J.R., Holmes M.C. Inhibition of 11beta-hydroxysteroid dehydrogenase, the foetoplacental barrier to maternal glucocorticoids, permanently programs amygdala GR mRNA expression and anxiety-like behaviour in the offspring. Eur. J. Neurosci. 2000, 12:1047-1054.
97. Wust S., Entringer S., Federenko I.S., Schlotz W., Hellhammer D.H. Birth weight is associated with salivary cortisol responses to psychosocial stress in adult life. Psychoneuroendocrinology 2005, 30:591-598.
98. Yehuda R., Engel S.M., Brand S.R., Seckl J., Marcus S.M., Berkowitz G.S. Transgenerational effects of posttraumatic stress disorder in babies of mothers exposed to the World Trade Center attacks during pregnancy. J. Clin. Endocrinol. Metab. 2005, 90(7):4115-4118.